U.S. Vaccine Market Growth 2012 - 2018

Transparency Market Research

U.S. Vaccine Market - Industry Analysis, Size, Share, Growth, And Forecast 2012 - 2018

Published Date 13-Sep-2013

82 Page Report

Buy Now

Request Sample

Press Release

U.S. Vaccine Market is Expected to Reach USD 17.4 Billion by 2018: Transparency Market Research

Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

U.S. Vaccine Market

REPORT DESCRIPTION

U.S. Vaccine Market - Industry Analysis, Size, Share, Growth, And Forecast 2012 - 2018 According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018", the U.S. vaccine market is estimated to be worth USD 12.8 billion in 2012 and is further expected to reach USD 17.4 billion by 2018, growing at a CAGR of 5.3% from 2012 to 2018. Human vaccine segment occupies about 80% of the U.S. vaccine market. Browse the database at http://www.transparencymarketresearch.com/us-vaccine-market.html U.S. will continue to lead the global vaccine market due to rising prevalence of infectious diseases in humans and animals, and advancement in biotechnology in the region. Short functional shelf life of certain vaccines will have negative impact on the market growth, but huge product pipeline of the multinational firms will overcome this concern and will drive the future growth of the market. Pediatric vaccine segment in the U.S. human vaccine market enjoys high share as well as high growth rate due to government compulsion for child immunization. Adult & adolescent vaccine market is expected to grow moderately over the next six years due to rising awareness and increasing vaccination for human papillomavirus (HPV) and such other viral diseases. Livestock vaccine is the leading segment of the overall U.S. animal...